Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Parathyroid hormone related-protein promotes epithelial-to-mesenchymal transition in prostate cancer.

Ongkeko WM, Burton D, Kiang A, Abhold E, Kuo SZ, Rahimy E, Yang M, Hoffman RM, Wang-Rodriguez J, Deftos LJ.

PLoS One. 2014 Jan 22;9(1):e85803. doi: 10.1371/journal.pone.0085803. eCollection 2014.

PMID:
24465715
[PubMed - in process]
Free PMC Article
2.

Nicotine promotes acquisition of stem cell and epithelial-to-mesenchymal properties in head and neck squamous cell carcinoma.

Yu MA, Kiang A, Wang-Rodriguez J, Rahimy E, Haas M, Yu V, Ellies LG, Chen J, Fan JB, Brumund KT, Weisman RA, Ongkeko WM.

PLoS One. 2012;7(12):e51967. doi: 10.1371/journal.pone.0051967. Epub 2012 Dec 26.

PMID:
23300583
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt.

Kuo SZ, Blair KJ, Rahimy E, Kiang A, Abhold E, Fan JB, Wang-Rodriguez J, Altuna X, Ongkeko WM.

BMC Cancer. 2012 Nov 24;12:556. doi: 10.1186/1471-2407-12-556.

PMID:
23176396
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cigarette smoke promotes drug resistance and expansion of cancer stem cell-like side population.

An Y, Kiang A, Lopez JP, Kuo SZ, Yu MA, Abhold EL, Chen JS, Wang-Rodriguez J, Ongkeko WM.

PLoS One. 2012;7(11):e47919. doi: 10.1371/journal.pone.0047919. Epub 2012 Nov 5.

PMID:
23144836
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Progress and pitfalls in the identification of cancer stem cell-targeting therapies in head and neck squamous cell carcinoma.

Kiang A, Yu MA, Ongkeko WM.

Curr Med Chem. 2012;19(35):6056-64. Review.

PMID:
22963569
[PubMed - indexed for MEDLINE]
6.

Activation of PDGFR and EGFR promotes the acquisition of a stem cell-like phenotype in schwannomas.

Yi D, Kuo SZ, Zheng H, Abhold EL, Brown CM, Doherty JK, Wang-Rodriguez J, Harris JP, Ongkeko WM.

Otol Neurotol. 2012 Dec;33(9):1640-7. doi: 10.1097/MAO.0b013e31826a540d.

PMID:
22935817
[PubMed - indexed for MEDLINE]
7.

EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells.

Abhold EL, Kiang A, Rahimy E, Kuo SZ, Wang-Rodriguez J, Lopez JP, Blair KJ, Yu MA, Haas M, Brumund KT, Altuna X, Patel A, Weisman RA, Ongkeko WM.

PLoS One. 2012;7(2):e32459. doi: 10.1371/journal.pone.0032459. Epub 2012 Feb 27.

PMID:
22384257
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.

Abhold E, Rahimy E, Wang-Rodriguez J, Blair KJ, Yu MA, Brumund KT, Weisman RA, Ongkeko WM.

BMC Res Notes. 2011 Dec 21;4:553. doi: 10.1186/1756-0500-4-553.

PMID:
22188703
[PubMed]
Free PMC Article
9.

EGF and bFGF promote invasion that is modulated by PI3/Akt kinase and Erk in vestibular schwannoma.

Blair KJ, Kiang A, Wang-Rodriguez J, Yu MA, Doherty JK, Ongkeko WM.

Otol Neurotol. 2011 Feb;32(2):308-14. doi: 10.1097/MAO.0b013e318206fc3d.

PMID:
21178801
[PubMed - indexed for MEDLINE]
10.

Potential role of imatinib mesylate (Gleevec, STI-571) in the treatment of vestibular schwannoma.

Altuna X, Lopez JP, Yu MA, Arandazi MJ, Harris JP, Wang-Rodriguez J, An Y, Dobrow R, Doherty JK, Ongkeko WM.

Otol Neurotol. 2011 Jan;32(1):163-70. doi: 10.1097/MAO.0b013e3182009665.

PMID:
21157293
[PubMed - indexed for MEDLINE]
11.

Real-time imaging of tumor progression in a fluorescent orthotopic mouse model of thyroid cancer.

Tran Cao HS, Kaushal S, Snyder CS, Ongkeko WM, Hoffman RM, Bouvet M.

Anticancer Res. 2010 Nov;30(11):4415-22.

PMID:
21115887
[PubMed - indexed for MEDLINE]
12.

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.

Wang XQ, Ongkeko WM, Chen L, Yang ZF, Lu P, Chen KK, Lopez JP, Poon RT, Fan ST.

Hepatology. 2010 Aug;52(2):528-39. doi: 10.1002/hep.23692.

PMID:
20683952
[PubMed - indexed for MEDLINE]
13.

ABCG2: the key to chemoresistance in cancer stem cells?

An Y, Ongkeko WM.

Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1529-42. doi: 10.1517/17425250903228834. Review.

PMID:
19708828
[PubMed - indexed for MEDLINE]
14.

p73 expression and function in vestibular schwannoma.

Ahmad ZK, Altuna X, Lopez JP, An Y, Wang-Rodriguez J, Juneja VR, Chen JS, Arandazi MJ, Aguilera J, Harris JP, Ongkeko WM.

Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):662-9. doi: 10.1001/archoto.2009.79.

PMID:
19620587
[PubMed - indexed for MEDLINE]
15.

Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma.

Chu TS, Chen JS, Lopez JP, Pardo FS, Aguilera J, Ongkeko WM.

Arch Otolaryngol Head Neck Surg. 2008 Sep;134(9):979-84. doi: 10.1001/archotol.134.9.979.

PMID:
18794444
[PubMed - indexed for MEDLINE]
16.

Gefitinib (Iressa) potentiates the effect of ionizing radiation in thyroid cancer cell lines.

Lopez JP, Wang-Rodriguez J, Chang CY, Sneh G, Yu MA, Pardo FS, Aguilera J, Ongkeko WM.

Laryngoscope. 2008 Aug;118(8):1372-6. doi: 10.1097/MLG.0b013e318172aae4.

PMID:
18475209
[PubMed - indexed for MEDLINE]
17.

Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.

Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM.

Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1022-7.

PMID:
17938326
[PubMed - indexed for MEDLINE]
18.

Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis.

Pham TT, Ongkeko WM, An Y, Yi ES.

Laryngoscope. 2007 Feb;117(2):253-7.

PMID:
17277618
[PubMed - indexed for MEDLINE]
19.

STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.

Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM.

Laryngoscope. 2006 Aug;116(8):1409-16.

PMID:
16885745
[PubMed - indexed for MEDLINE]
20.

Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging agents.

Ongkeko WM, An Y, Chu TS, Aguilera J, Dang CL, Wang-Rodriguez J.

Laryngoscope. 2006 Aug;116(8):1390-6.

PMID:
16885742
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk